The effectiveness of non-surgical interventions for common plantar digital compressive neuropathy (Morton's neuroma): a systematic review and meta-analysis

Barry G Matthews, Sheree E Hurn, Michael P Harding, Rachel A Henry, Robert S Ware, Barry G Matthews, Sheree E Hurn, Michael P Harding, Rachel A Henry, Robert S Ware

Abstract

Background: Morton's neuroma (MN) is a compressive neuropathy of the common plantar digital nerve. It is a common compressive neuropathy often causing significant pain which limits footwear choices and weight bearing activities. This paper aims to review non-surgical interventions for MN, to evaluate the evidence base for the clinical management of MN.

Methods: Electronic biomedical databases (CINAHL, EMBASE, MEDLINE and Cochrane) were searched to January 2018 for studies evaluating the effectiveness of non-surgical interventions for Morton's neuroma. Outcome measures of interest were treatment success rate (SR) (binary) and pain as measured using 100-point visual analogue scale (VAS) (continuous). Studies with and without control groups were included and were evaluated for methodological quality using the Downs and Black Quality Index. Results from randomised controlled trials (RCT) were compared between-groups, and case series were compared pre- versus post-treatment. Effect estimates are presented as odds ratios (OR) for binary data or mean differences (MD) for continuous data. Random effects models were used to pool effect estimates across studies where similar treatments were used. Heterogeneity was assessed using the I 2 statistic.

Results: A total of 25 studies met the inclusion criteria, seven RCTs and 18 pre/post case series. Eight different interventions were identified, with corticosteroid or sclerosing injections being the most often reported (seven studies each). Results from a meta-analysis of two RCTs found corticosteroid injection decreased pain more than control on VAS (WMD: -5.3, 95%CI: -7.5 to - 3.2). Other RCTs reported efficacy of: manipulation/mobilisation versus control (MD: -15.3, 95%CI: -29.6 to - 1.0); extracorporeal shockwave therapy versus control (MD: -5.9, 95%CI: -21.9 to 10.1). Treatment success was assessed for extracorporeal shockwave therapy versus control (OR: 0.3, 95%CI: 0.0 to 7.1); and corticosteroid injection vs footwear/padding (OR: 6.0, 95%CI: 1.9 to 19.2). Sclerosing and Botox injections, radiofrequency ablation and cryoneurolysis have been investigated by case series studies, however these were of limited methodological quality.

Conclusions: Corticosteroid injections and manipulation/mobilisation are the two interventions with the strongest evidence for pain reduction, however high-quality evidence for a gold standard intervention was not found. Although the evidence base is expanding, further high quality RCTs are needed.

Keywords: Common plantar digital nerve; Compression neuropathy; Morton’s neuroma; Non-surgical intervention.

Conflict of interest statement

Not applicable.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow diagram of study selection
Fig. 2
Fig. 2
Clinical evidence summary: Morton’s neuroma non-surgical interventions for pain reduction. RCT Randomised controlled trial; Clinical evidence summary may be used in combination with the existing published treatment pathways for Morton’s neuroma; *No studies assessing the effect of orthoses on foot function related to Morton’s neuroma were found by the review; #Statistically significant reduction in pain may not be a clinically significant reduction in pain (no data on the minimal important difference for pain reduction in Morton’s neuroma was found)
Fig. 3
Fig. 3
Meta-analysis for RCTs of corticosteroid injection on continuous outcomes (Pain VAS 0–100). VAS visual analogue scale; WMD weighted mean difference; CI confidence interval
Fig. 4
Fig. 4
Mean difference (with 95% CI) for RCT continuous outcomes (Pain VAS 0–100). *Two or more studies required to calculate I2 statistic; #UG single injection and NUG three injections outcome data combined; VAS visual analogue scale; MD mean difference; CI confidence interval; UG ultrasound guided; NUG non-ultrasound guided; ESWT extracorporeal shock wave therapy
Fig. 5
Fig. 5
Odds ratio (with 95% CI) for RCT binary outcomes. *Three or more studies required to calculate I2 statistic; OR odds ratio; CI confidence interval; UG ultrasound guided; NUG non-ultrasound guided; ESWT Extracorporeal shockwave therapy
Fig. 6
Fig. 6
Effect of intervention on pre/post case series continuous outcomes (Pain VAS 0–100). *Two or more studies required to calculate I2 statistic; VAS visual analogue scale; MD mean difference; CI confidence interval; ESWT extracorporeal shock wave therapy
Fig. 7
Fig. 7
Effect of intervention on case series binary outcomes. *Three or more studies required to calculate I2 statistic; SR success rate; CI confidence interval; ESWT Extracorporeal shockwave therapy

References

    1. Markovic M, Chrichton K, Read JW, Lam P, Slater HK. Effectiveness of ultrasound-guided corticosteroid injection in the treatment of Morton's neuroma. Foot Ankle Int. 2008;29:483–487. doi: 10.3113/FAI.2008.0483.
    1. Cashley DG, Cochrane L. Manipulation in the treatment of plantar digital neuralgia: a retrospective study of 38 cases. J Chiropr Med. 2015;14:90–98. doi: 10.1016/j.jcm.2015.04.003.
    1. Saygi B, Yildirim Y, Saygi EK, Kara H, Esemenli T. Morton neuroma: comparative results of two conservative methods. Foot Ankle Int. 2005;26:556–559. doi: 10.1177/107110070502600711.
    1. Bennett GL, Graham CE, Mauldin DM. Morton's interdigital neuroma: a comprehensive treatment protocol. Foot Ankle Int. 1995;16:760–763. doi: 10.1177/107110079501601204.
    1. Dockery GL. The treatment of intermetatarsal neuromas with 4% alcohol sclerosing injections. J Foot Ankle Surg. 1999;38:403–408. doi: 10.1016/S1067-2516(99)80040-4.
    1. Climent JM, Mondejar-Gomez F, Rodriguez-Ruiz C, Diaz-Llopis I, Gomez-Gallego D, Martin-Medina P. Treatment of Morton neuroma with botulinum toxin a: a pilot study. Clin Drug Investig. 2013;33:497–503. doi: 10.1007/s40261-013-0090-0.
    1. Hughes RJ, Ali K, Jones H, Kendall S, Connell DA. Treatment of Morton's neuroma with alcohol injection under sonographic guidance: follow-up of 101 cases. AJR Am J Roentgenol. 2007;188:1535–1539. doi: 10.2214/AJR.06.1463.
    1. Pasquali C, Vulcano E, Novario R, Varotto D, Montoli C, Volpe A. Ultrasound-guided alcohol injection for Morton's neuroma. Foot Ankle Int. 2015;36:55–59. doi: 10.1177/1071100714551386.
    1. Deniz S, Purtuloglu T, Tekindur S, Cansiz KH, Yetim M, Kılıckaya O, et al. Ultrasound-guided pulsed radio frequency treatment in Morton's neuroma. J Am Podiatr Med Assoc. 2015;105:302–306. doi: 10.7547/13-128.1.
    1. Chuter GSJ, Chua YP, Connell DA, Blackney MC. Ultrasound-guided radiofrequency ablation in the management of interdigital (Morton's) neuroma. Skelet Radiol. 2013;42:107–111. doi: 10.1007/s00256-012-1527-x.
    1. Pasero G, Marson P. Filippo Civinini (1805-1844) and the discovery of plantar neuroma. Reumatismo. 2006;58:319–322.
    1. Durlacher L. A treatise on corns, bunions, the disease of nails, and the general management of the feet. London: Simpkin, Marshall and Co; 1845.
    1. Morton T. A peculiar and painful affection of the fourth metatarsophalangeal articulation. Am J Med Sci. 1876;71:37–45. doi: 10.1097/00000441-187601000-00002.
    1. Latinovic R, Gulliford MC, Hughes RA. Incidence of common compressive neuropathies in primary care. J Neurol Neurosurg Psychiatry. 2006;77:263–265. doi: 10.1136/jnnp.2005.066696.
    1. Mahadevan D, Venkatesan M, Bhatt R, Bhatia M. Diagnostic accuracy of clinical tests for Morton's neuroma compared with ultrasonography. J Foot Ankle Surg. 2015;54:549–553. doi: 10.1053/j.jfas.2014.09.021.
    1. Owens R, Gougoulias N, Guthrie H, Sakellariou A. Morton's neuroma: clinical testing and imaging in 76 feet, compared to a control group. Foot Ankle Surg. 2011;17:197–200. doi: 10.1016/j.fas.2010.07.002.
    1. Bignotti B, Signori A, Sormani MP, Molfetta L, Martinoli C, Tagliafico A. Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis. Eur Radiol. 2015;25:2254–2262. doi: 10.1007/s00330-015-3633-3.
    1. Symeonidis PD, Iselin LD, Simmons N, Fowler S, Dracopoulos G, Stavrou P. Prevalence of interdigital nerve enlargements in an asymptomatic population. Foot Ankle Int. 2012;33:543–547. doi: 10.3113/FAI.2012.0543.
    1. Hyer CF, Mehl LR, Block AJ, Vancourt RB. Treatment of recalcitrant intermetatarsal neuroma with 4% sclerosing alcohol injection: a pilot study. J Foot Ankle Surg. 2005;44:287–291. doi: 10.1053/j.jfas.2005.04.010.
    1. Fanucci E, Masala S, Fabiano S, Perugia D, Squillaci E, Varrucciu V, et al. Treatment of intermetatarsal Morton's neuroma with alcohol injection under US guide: 10-month follow-up. Eur Radiol. 2004;14:514–518. doi: 10.1007/s00330-003-2057-7.
    1. Larson EE, Barrett SL, Battiston B, Maloney CT, Jr, Dellon AL. Accurate nomenclature for forefoot nerve entrapment: a historical perspective. J Am Podiatr Med Assoc. 2005;95:298–306. doi: 10.7547/0950298.
    1. Hassouna H, Singh D, Taylor H, Johnson S. Ultrasound guided steroid injection in the treatment of interdigital neuralgia. Acta Orthop Belg. 2007;73:224–229.
    1. Magnan B, Marangon A, Frigo A, Bartolozzi P. Local phenol injection in the treatment of interdigital neuritis of the foot (Morton's neuroma) Chir Organi Mov. 2005;90:371–377.
    1. Levitsky KA, Alman BA, Jevsevar DS, Morehead J. Digital nerves of the foot: anatomic variations and implications regarding the pathogenesis of interdigital neuroma. Foot Ankle. 1993;14:208–214. doi: 10.1177/107110079301400406.
    1. Thomas JL, ELt B, Chaney DM, Dinucci KA, Eickmeier K, Rubin LG, Stapp MD, Vanore JV. Diagnosis and treatment of forefoot disorders. Section 3. Morton's intermetatarsal neuroma. J Foot Ankle Surg. 2009;48:251–256. doi: 10.1053/j.jfas.2008.12.005.
    1. Adams WR., 2nd Morton’s neuroma. Clin Podiatr Med Surg. 2010;27:535–545. doi: 10.1016/j.cpm.2010.06.004.
    1. Schreiber K, Khodaee M, Poddar S, Tweed EM, Inquiry C. What is the best way to treat Morton's neuroma? J Fam Pract. 2011;60:157–168.
    1. DiPreta JA. Metatarsalgia, lesser toe deformities, and associated disorders of the forefoot. Med Clin North Am. 2014;98:233–251. doi: 10.1016/j.mcna.2013.10.003.
    1. Di Caprio F, Meringolo R, Shehab Eddine M, Ponziani L. Morton’s interdigital neuroma of the foot. A literature review. Foot Ankle Surg. 2018. 10.1016/j.fas.2017.01.007.
    1. Jain S, Mannan K. The diagnosis and management of Morton's neuroma: a literature review. Foot Ankle Spec. 2013;6:307–317. doi: 10.1177/1938640013493464.
    1. Thomson CE, Gibson JN, Martin D. Interventions for the treatment of Morton's neuroma. Cochrane Database Syst Rev. 2004. 10.1002/14651858.CD003118.pub2.
    1. Valisena S, Petri GJ, Ferrero A. Treatment of Morton's neuroma: a systematic review. Foot Ankle Surg. 2017. 10.1016/j.fas.2017.03.010.
    1. Macquarie Dictionary Online, 2016, Macquarie Dictionary Publishers, an imprint of Pan Macmillan Australia Pty Ltd. . Accessed 3 Feb 2019.
    1. Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence. BMC Med Res Methodol. 2009;9:34. doi: 10.1186/1471-2288-9-34.
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009. 10.1371/journal.pmed.1000100.
    1. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–384. doi: 10.1136/jech.52.6.377.
    1. Barton CJ, Bonanno DR, Carr J, Neal BS, Malliaras P, Franklyn-Miller A, et al. Running retraining to treat lower limb injuries: a mixed-methods study of current evidence synthesised with expert opinion. Br J Sports Med. 2016;50:513–526. doi: 10.1136/bjsports-2015-095278.
    1. Cumming J. Does anyone have specific guidance for how to interpret question 27 (power) of the Downs and Black (1998) checklist? . Accessed 3 Feb 2019.
    1. Thomson CE, Beggs I, Martin DJ, McMillan D, Edwards RT, Russell D, et al. Methylprednisolone injections for the treatment of Morton neuroma: a patient-blinded randomized trial. J Bone Joint Surg Am. 2013;95:790–798. doi: 10.2106/JBJS.I.01780.
    1. Mahadevan D, Attwal M, Bhatt R, Bhatia M. Corticosteroid injection for Morton's neuroma with or without ultrasound guidance: a randomised controlled trial. Bone Joint J. 2016;98B:498–503. doi: 10.1302/0301-620X.98B4.36880.
    1. Lizano-Diez X, Gines-Cespedosa A, Alentorn-Geli E, Perez-Prieto D, Gonzalez-Lucena G, Gamba C, et al. Corticosteroid injection for the treatment of Morton's neuroma: a prospective, double-blinded, randomized, placebo-controlled trial. Foot Ankle Int. 2017;38:944–951. doi: 10.1177/1071100717709569.
    1. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2:175–184. doi: 10.1016/0304-3959(76)90113-5.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557.
    1. MacDougall-Davis SR, Kettley L, Cook TM. The ‘go-between’ study: a simulation study comparing the ‘Traffic Lights’ and ‘SBAR’ tools as a means of communication between anaesthetic staff. Anaesthesia. 2016;71:764–772. doi: 10.1111/anae.13464.
    1. Phillips P, Evans AM. One pair must last a lifetime. Foot care in diabetes. Aust Fam Physician. 2002;31:741–744.
    1. Evans AM. The flat-footed child -- to treat or not to treat: what is the clinician to do? J Am Podiatr Med Assoc. 2008;98:386–393. doi: 10.7547/0980386.
    1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J. 1996;312:71–72. doi: 10.1136/bmj.312.7023.71.
    1. Govender N, Kretzmann H, Price JL, Brantingham JW, Globe G. A single-blinded randomized placebo-controlled clinical trial of manipulation and mobilization in the treatment of Morton's neuroma. J Am Chiropr Assoc. 2007;44:8–18.
    1. Friedman T, Richman D, Adler R. Sonographically guided cryoneurolysis: preliminary experience and clinical outcomes. J Ultrasound Med. 2012;31:2025–2034. doi: 10.7863/jum.2012.31.12.2025.
    1. Kilmartin TE, Wallace WA. Effect of pronation and supination orthosis on Morton's neuroma and lower extremity function. Foot Ankle Int. 1994;15:256–262. doi: 10.1177/107110079401500505.
    1. Cazzato RL, Garnon J, Ramamurthy N, Tsoumakidou G, Caudrelier J, Thenint MA, et al. Percutaneous MR-guided Cryoablation of Morton’s neuroma: rationale and technical details after the first 20 patients. Cardiovasc Intervent Radiol. 2016;39:1491–1498. doi: 10.1007/s00270-016-1365-7.
    1. Seok H, Sang-Hyun K, Seung Yeol L, Sung Won P. Extracorporeal shockwave therapy in patients with Morton's neuroma. J Am Podiatr Med Assoc. 2016;106:93–99. doi: 10.7547/14-131.
    1. Masala S, Cuzzolino A, Morini M, Raguso M, Fiori R. Ultrasound-guided percutaneous radiofrequency for the treatment of Morton’s neuroma. Cardiovasc Intervent Radiol. 2018;41:137–144. doi: 10.1007/s00270-017-1786-y.
    1. Park YH, Lee JW, Choi GW, Kim HJ. Risk factors and the associated cutoff values for failure of corticosteroid injection in treatment of Morton’s neuroma. Int Orthop. 2017.
    1. Perini L, Perini C, Tagliapietra M, Varotto D, Valcarenghi A, Postorino A, et al. Percutaneous alcohol injection under sonographic guidance in Morton's neuroma: follow-up in 220 treated lesions. Radiol Med. 2016;121:597–604. doi: 10.1007/s11547-016-0622-9.
    1. Mahadevan D, Salmasi M, Whybra N, Nanda A, Gaba S, Mangwani J. What factors predict the need for further intervention following corticosteroid injection of Morton's neuroma? Foot Ankle Surg. 2016;22:9–11. doi: 10.1016/j.fas.2015.03.007.
    1. Johnson JE, Johnson KA, Unni KK. Persistent pain after excision of an interdigital neuroma. Results of reoperation. J Bone Joint Surg Am. 1988;70:651–657. doi: 10.2106/00004623-198870050-00003.
    1. Sobiesk GA, Wertheimer SJ, Schulz R, Dalfovo M. Sonographic evaluation of interdigital neuromas. J Foot Ankle Surg. 1997;36:364–366. doi: 10.1016/S1067-2516(97)80038-5.
    1. Greenfield J, Rea J Jr, Ilfeld FW. Morton's interdigital neuroma. Indications for treatment by local injections versus surgery. Clin Orthop Relat Res. 1984;185:142–4.
    1. Rassmussen MR, Kitaoka HB, Pantzer GL. Nonoperative treatment of plantar interdigital neuroma with single corticosteroid injection. Clin Orthop Relat Res. 1996;326:188–93.
    1. Strong G, Thomas PS. Conservative treatment of Morton's neuroma. Orthop Rev. 1987;16:343–345.
    1. Stecco C, Fantoni I, Macchi V, Del Borrello M, Porzionato A, Biz C, et al. The role of fasciae in Civinini–Morton's syndrome. J Anat. 2015;227:654–664. doi: 10.1111/joa.12371.
    1. Giakoumis M, Ryan JD, Jani J. Histologic evaluation of intermetatarsal Morton's neuroma. J Am Podiatr Med Assoc. 2013;103:218–222. doi: 10.7547/1030218.
    1. Root M, Orein W, Weed J. Normal and abnormal function of the foot. 1st. Los Angeles: Clinical Biomechanics Corporation; 1977.
    1. Noakes H, Payne C. The reliability of the manual supination resistance test. J Am Podiatr Med Assoc. 2003;93:185–189. doi: 10.7547/87507315-93-3-185.
    1. Kirby K. Emerging concepts in podiatric biomechanics. Podiatry Today. 2006;19:36–48.
    1. McPoil TG, Hunt GC. Evaluation and management of foot and ankle disorders: present problems and future directions. J Orthop Sports Phys Ther. 1995;21:381–388. doi: 10.2519/jospt.1995.21.6.381.
    1. Jarvis HL, Nester CJ, Bowden PD, Jones RK. Challenging the foundations of the clinical model of foot function: further evidence that the root model assessments fail to appropriately classify foot function. J Foot Ankle Res. 2017;10:7. doi: 10.1186/s13047-017-0189-2.
    1. Fridman R, Cain JD, Weil L., Jr Extracorporeal shockwave therapy for interdigital neuroma. J Am Podiatr Med Assoc. 2009;99:191–193. doi: 10.7547/0980191.
    1. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61:102–109. doi: 10.1016/j.jclinepi.2007.03.012.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Br Med J. 2010;340.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe